Cargando…
Expanding COVID-19 Vaccine Availability: Role for Combined Orthogonal Serology Testing (COST)
Background: The persisting Coronavirus disease 2019 (COVID-19) pandemic and limited vaccine supply has led to a shift in global health priorities to expand vaccine coverage. Relying on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) molecular testing alone cannot reveal the infection pr...
Autores principales: | Narasimhan, Madhusudhanan, Mahimainathan, Lenin, Araj, Ellen, Clark, Andrew E, Wilkinson, Kathleen, Yekkaluri, Sruthi, Tiro, Jasmin, Lee, Francesca M, Balani, Jyoti, Sarode, Ravi, Singal, Amit G, Muthukumar, Alagarraju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069830/ https://www.ncbi.nlm.nih.gov/pubmed/33924340 http://dx.doi.org/10.3390/vaccines9040376 |
Ejemplares similares
-
Silent SARS-CoV-2 Infections, Waning Immunity, Serology Testing, and COVID-19 Vaccination: A Perspective
por: Narasimhan, Madhusudhanan, et al.
Publicado: (2021) -
Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines
por: Narasimhan, Madhusudhanan, et al.
Publicado: (2021) -
‘nAb’ the self-reactive activity in the COVID-19 combat
por: Narasimhan, Madhusudhanan, et al.
Publicado: (2021) -
Evaluation of SARS-CoV-2 Serological Testing in Patients with Multiple Myeloma and Other Hematologic Malignancies on Monoclonal Antibody Therapies
por: Mahimainathan, Lenin, et al.
Publicado: (2020) -
Translation suppression underlies the restrained COVID-19 mRNA vaccine response in the high-risk immunocompromised group
por: Kim, Kangsan, et al.
Publicado: (2022)